Chuanhe Yang

721 total citations
15 papers, 593 citations indexed

About

Chuanhe Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chuanhe Yang has authored 15 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Chuanhe Yang's work include Chromatin Remodeling and Cancer (4 papers), Protein Degradation and Inhibitors (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Chuanhe Yang is often cited by papers focused on Chromatin Remodeling and Cancer (4 papers), Protein Degradation and Inhibitors (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Chuanhe Yang collaborates with scholars based in United States, China and Japan. Chuanhe Yang's co-authors include Lawrence M. Pfeffer, Aruna Murti, Junming Yue, Michelle Sims, Yinan Wang, Stefan N. Constantinescu, Ed Croze, Wei Shi, Lawrence M. Blatt and Jerald E. Mullersman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Chuanhe Yang

15 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanhe Yang United States 12 344 222 221 183 50 15 593
Sophie Couvé France 11 495 1.4× 219 1.0× 259 1.2× 118 0.6× 33 0.7× 20 779
Stella Lam United States 8 350 1.0× 377 1.7× 238 1.1× 223 1.2× 37 0.7× 10 689
Emily N. Arner United States 8 260 0.8× 175 0.8× 148 0.7× 213 1.2× 38 0.8× 10 567
Shaokun Shu China 11 330 1.0× 208 0.9× 167 0.8× 108 0.6× 24 0.5× 18 575
Haritha Mathsyaraja United States 10 373 1.1× 131 0.6× 138 0.6× 81 0.4× 45 0.9× 10 520
Mohamad A. Salkeni United States 11 317 0.9× 237 1.1× 140 0.6× 69 0.4× 29 0.6× 42 603
Iris de Rink Netherlands 11 478 1.4× 348 1.6× 161 0.7× 305 1.7× 36 0.7× 19 882
Sabita Sankar United States 10 534 1.6× 152 0.7× 155 0.7× 83 0.5× 47 0.9× 15 668
Buyou Chen China 16 386 1.1× 109 0.5× 149 0.7× 100 0.5× 46 0.9× 23 523
Christian Werno Germany 9 331 1.0× 127 0.6× 246 1.1× 183 1.0× 53 1.1× 14 569

Countries citing papers authored by Chuanhe Yang

Since Specialization
Citations

This map shows the geographic impact of Chuanhe Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanhe Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanhe Yang more than expected).

Fields of papers citing papers by Chuanhe Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanhe Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanhe Yang. The network helps show where Chuanhe Yang may publish in the future.

Co-authorship network of co-authors of Chuanhe Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanhe Yang. A scholar is included among the top collaborators of Chuanhe Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanhe Yang. Chuanhe Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Hwang, Dong‐Jin, et al.. (2025). Structural Activity Relationship Analysis of New Diphenyl PFI-3 Analogues Targeting for the Treatment of Glioblastoma. Pharmaceuticals. 18(5). 608–608. 1 indexed citations
2.
Yang, Chuanhe, Yali He, Yinan Wang, et al.. (2023). Next‐generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma. Journal of Cellular and Molecular Medicine. 27(18). 2770–2781. 7 indexed citations
3.
Wang, Yinan, Chuanhe Yang, Michelle Sims, et al.. (2022). SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo. Cancer Letters. 533. 215614–215614. 14 indexed citations
4.
Bhattacharya, Sujoy, Chuanhe Yang, Yinan Wang, et al.. (2022). STAT3 suppresses the AMPKα/ULK1‐dependent induction of autophagy in glioblastoma cells. Journal of Cellular and Molecular Medicine. 26(14). 3873–3890. 13 indexed citations
5.
He, Yali, Chuanhe Yang, Yinan Wang, et al.. (2021). Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorganic & Medicinal Chemistry. 53. 116533–116533. 9 indexed citations
6.
Yang, Chuanhe, Yinan Wang, Michelle Sims, et al.. (2021). Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma. Pharmaceuticals. 14(9). 904–904. 13 indexed citations
7.
Zhang, Tao, Guannan Zhao, Chuanhe Yang, et al.. (2018). Lentiviral vector mediated-ASAP1 expression promotes epithelial to mesenchymal transition in ovarian cancer cells. Oncology Letters. 15(4). 4432–4438. 19 indexed citations
8.
Wang, Baojin, Guannan Zhao, Ziyun Du, et al.. (2017). KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells. Biochemical and Biophysical Research Communications. 484(3). 486–492. 26 indexed citations
9.
Zhao, Guannan, Xuan Ouyang, Yinan Wang, et al.. (2016). Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells. Journal of Cancer. 8(1). 57–64. 94 indexed citations
10.
Wang, Yinan, Chuanhe Yang, Qingqing Gu, et al.. (2015). KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells. PLoS ONE. 10(6). e0130341–e0130341. 58 indexed citations
11.
Guo, Yuqi, Peng Tian, Chuanhe Yang, et al.. (2013). Silencing the Double-Stranded RNA Binding Protein DGCR8 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion. Pharmaceutical Research. 32(3). 769–778. 33 indexed citations
12.
Chen, Zixuan, Jianmin Wu, Chuanhe Yang, et al.. (2012). DiGeorge Syndrome Critical Region 8 (DGCR8) Protein-mediated microRNA Biogenesis Is Essential for Vascular Smooth Muscle Cell Development in Mice. Journal of Biological Chemistry. 287(23). 19018–19028. 49 indexed citations
13.
Johnson, Leonard R., Shirley A. McCormack, Chuanhe Yang, Susan R. Pfeffer, & Lawrence M. Pfeffer. (1999). EGF induces nuclear translocation of STAT2 without tyrosine phosphorylation in intestinal epithelial cells. American Journal of Physiology-Cell Physiology. 276(2). C419–C425. 26 indexed citations
14.
Yang, Chuanhe, Aruna Murti, & Lawrence M. Pfeffer. (1998). STAT3 complements defects in an interferon-resistant cell line: Evidence for an essential role for STAT3 in interferon signaling and biological activities. Proceedings of the National Academy of Sciences. 95(10). 5568–5572. 116 indexed citations
15.
Yang, Chuanhe, Wei Shi, Aruna Murti, et al.. (1996). Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor. Journal of Biological Chemistry. 271(14). 8057–8061. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026